United States
Physician–scientist in training with a focus on pediatric oncology. Currently a postdoctoral fellow at St. Jude Children’s Research Hospital, working at the interface of cancer immunology and developmental neurobiology. My background includes medical training in Indonesia and the United States, and immunology research at Harvard Medical School and the Broad Institute, with over 20 publications in journals such as Cell Chemical Biology, Trends in Cancer, The Lancet, and Nature. I aspire to a career as a pediatric oncologist and physician–scientist. My goal is to combine scientific rigor with compassionate, creative care; making the journey of healing as engaging and supportive as possible for every child. Outside the hospital and lab, I enjoy writing, learning history, exploring nature, and hitting the open road for new adventures.
Researching oncogenic mechanisms and therapeutic vulnerabilities in pediatric brain cancer, leveraging cancer proteomics, systems immunology, and next-generation interactome mapping to inform translational strategies
Care of patients with sarcomas and rare malignancies, including participation in early-phase oncology trials
Comprehensive pediatric care with emphasis on multidisciplinary care and family engagement
Focused on utilizing targeted protein degradation for cellular immunotherapy and stem cell transplant. Managed projects to explore and develop synthetic biology strategies aimed at improving precision, safety, and deployability of these therapeutic modalities. Techniques utilized include cell & protein engineering; flow cytometry; genome editing; cell culture; various in vitro assays; and comprehensive DNA/RNA expression analysis.
Worked with the Antibody Discovery Group / Center of the Development of Therapeutics on refining nanobody-based systems to enhance targeted protein degradation. Conducted affinity reagent panning to optimize the screening pipeline of experimental constructs.
Recruited & organized ~20 investigative teams from Indonesian hospitals and academic institutions to assess key global surgical indicators related to COVID-19 infection